Benoı̂t J. Van den Eynde

16.0k total citations · 5 hit papers
119 papers, 11.6k citations indexed

About

Benoı̂t J. Van den Eynde is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Benoı̂t J. Van den Eynde has authored 119 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Immunology, 60 papers in Molecular Biology and 33 papers in Oncology. Recurrent topics in Benoı̂t J. Van den Eynde's work include Immunotherapy and Immune Responses (72 papers), Immune Cell Function and Interaction (34 papers) and Ubiquitin and proteasome pathways (25 papers). Benoı̂t J. Van den Eynde is often cited by papers focused on Immunotherapy and Immune Responses (72 papers), Immune Cell Function and Interaction (34 papers) and Ubiquitin and proteasome pathways (25 papers). Benoı̂t J. Van den Eynde collaborates with scholars based in Belgium, France and United Kingdom. Benoı̂t J. Van den Eynde's co-authors include Thierry Boon, Pierre van der Bruggen, Vincent Stroobant, Pierre G. Coulie, Didier Colau, Luc Pilotte, Catherine Uyttenhove, Ivan Théate, Nicolas Parmentier and Nathalie Vigneron and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Benoı̂t J. Van den Eynde

116 papers receiving 11.5k citations

Hit Papers

Evidence for a tumoral immune resistance mechanism based ... 1997 2026 2006 2016 2003 2014 2012 1997 2005 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
    2003 1.8k citations Catherine Uyttenhove, Luc Pilotte et al. profile →
  2. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
    2014 845 citations Pierre G. Coulie, Benoı̂t J. Van den Eynde et al. profile →
  3. Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
    2012 554 citations Benoı̂t J. Van den Eynde et al. Cancer Research profile →
  4. T cell defined tumor antigens
    1997 516 citations Benoı̂t J. Van den Eynde, Pierre van der Bruggen profile →
  5. HUMAN T CELL RESPONSES AGAINST MELANOMA
    2005 504 citations Thierry Boon, Pierre G. Coulie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benoı̂t J. Van den Eynde Belgium 54 6.9k 5.0k 4.5k 2.1k 821 119 11.6k
Vincent Stroobant Belgium 46 3.6k 0.5× 3.9k 0.8× 2.0k 0.5× 1.6k 0.8× 600 0.7× 106 8.1k
Peggy Scherle United States 47 2.9k 0.4× 4.6k 0.9× 2.9k 0.7× 771 0.4× 392 0.5× 154 10.0k
Didier Colau Belgium 36 3.5k 0.5× 2.3k 0.5× 2.1k 0.5× 1.5k 0.7× 546 0.7× 66 6.5k
James B. DuHadaway United States 37 1.7k 0.3× 2.5k 0.5× 1.1k 0.2× 2.9k 1.4× 1.1k 1.3× 75 6.2k
Zhihai Qin China 55 5.2k 0.8× 3.5k 0.7× 3.0k 0.7× 81 0.0× 144 0.2× 220 10.2k
Leonard Liebes United States 39 1.2k 0.2× 2.5k 0.5× 2.1k 0.5× 170 0.1× 153 0.2× 129 6.2k
Donald G. Payan United States 57 2.3k 0.3× 4.5k 0.9× 1.2k 0.3× 56 0.0× 286 0.3× 159 9.7k
Silvia Deaglio Italy 56 4.5k 0.7× 3.1k 0.6× 2.6k 0.6× 112 0.1× 217 0.3× 226 11.4k
Fabio Malavasi Italy 70 6.1k 0.9× 4.5k 0.9× 3.5k 0.8× 145 0.1× 135 0.2× 357 16.7k
Kjetil Taskén Norway 61 4.1k 0.6× 7.4k 1.5× 2.1k 0.5× 73 0.0× 228 0.3× 288 13.2k

Countries citing papers authored by Benoı̂t J. Van den Eynde

Since Specialization
Citations

This map shows the geographic impact of Benoı̂t J. Van den Eynde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoı̂t J. Van den Eynde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoı̂t J. Van den Eynde more than expected).

Fields of papers citing papers by Benoı̂t J. Van den Eynde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoı̂t J. Van den Eynde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoı̂t J. Van den Eynde. The network helps show where Benoı̂t J. Van den Eynde may publish in the future.

Co-authorship network of co-authors of Benoı̂t J. Van den Eynde

This figure shows the co-authorship network connecting the top 25 collaborators of Benoı̂t J. Van den Eynde. A scholar is included among the top collaborators of Benoı̂t J. Van den Eynde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoı̂t J. Van den Eynde. Benoı̂t J. Van den Eynde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Denanglaire, Sébastien, Abdulkader Azouz, Louis Boon, et al.. (2025). IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice. Cancer Immunology Research. 13(12). 2004–2022. 1 indexed citations
2.
Eynde, Benoı̂t J. Van den, et al.. (2025). Unlocking the mystery of the PD-1/PD-L1 axis: beyond the checkpoint hype. Frontiers in Immunology. 16. 1708873–1708873.
3.
Panetti, Silvia, Ramiro A. Ramirez-Valdez, Vineethkrishna Chandrasekar, et al.. (2024). Novel H-2Db-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice. Journal for ImmunoTherapy of Cancer. 12(10). e008998–e008998.
4.
Blackhall, Fiona, Adel Samson, K. Franks, et al.. (2023). 1502TiP A phase I/IIa trial of ChAdOx1 and MVA vaccines against MAGE-A3 and NY-ESO-1. Annals of Oncology. 34. S846–S846. 3 indexed citations
5.
Pfänder, Pauline, Luc Pilotte, Vincent Stroobant, et al.. (2023). Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes. Journal for ImmunoTherapy of Cancer. 11(6). e006728–e006728. 53 indexed citations
6.
Naulaerts, Stefan, et al.. (2022). T Cell–Mediated Targeted Delivery of Anti–PD-L1 Nanobody Overcomes Poor Antibody Penetration and Improves PD-L1 Blocking at the Tumor Site. Cancer Immunology Research. 10(6). 713–727. 15 indexed citations
7.
Crosignani, Stefano, et al.. (2019). Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors. Cancer Immunology Research. 8(1). 32–45. 55 indexed citations
8.
Stroobant, Vincent, Caroline Bouzin, Jean‐Christophe Renauld, et al.. (2019). Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most Cancers. Cancer Immunology Research. 8(1). 19–31. 45 indexed citations
9.
Zanker, Damien, David C. Tscharke, Mubing Duan, et al.. (2019). Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames. The Journal of Immunology. 202(12). 3370–3380. 21 indexed citations
10.
Vigneron, Nathalie, et al.. (2018). Cytosolic Processing Governs TAP-Independent Presentation of a Critical Melanoma Antigen. The Journal of Immunology. 201(7). 1875–1888. 18 indexed citations
11.
Hennequart, Marc, Luc Pilotte, Stefania Canè, et al.. (2017). Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance. Cancer Immunology Research. 5(8). 695–709. 137 indexed citations
12.
Théate, Ivan, Nicolas van Baren, Luc Pilotte, et al.. (2014). Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues. Cancer Immunology Research. 3(2). 161–172. 284 indexed citations
13.
Corbière, Véronique, Jacques Chapiro, Vincent Stroobant, et al.. (2011). Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases. Cancer Research. 71(4). 1253–1262. 142 indexed citations
14.
Huijbers, Ivo J., Paul Krimpenfort, Patrick Chomez, et al.. (2006). An Inducible Mouse Model of Melanoma Expressing a Defined Tumor Antigen. Cancer Research. 66(6). 3278–3286. 40 indexed citations
15.
Warren, Edus H., Nathalie Vigneron, Marc A. Gavin, et al.. (2006). An Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order. Science. 313(5792). 1444–1447. 160 indexed citations
16.
Chapiro, Jacques, Stéphane Claverol, Fanny Piette, et al.. (2006). Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation. The Journal of Immunology. 176(2). 1053–1061. 125 indexed citations
17.
Vigneron, Nathalie, Vincent Stroobant, Jacques Chapiro, et al.. (2004). An Antigenic Peptide Produced by Peptide Splicing in the Proteasome. Science. 304(5670). 587–590. 262 indexed citations
18.
Bilsborough, Janine, Catherine Uyttenhove, Didier Colau, et al.. (2002). TNF-Mediated Toxicity After Massive Induction of Specific CD8+ T Cells Following Immunization of Mice with a Tumor-Specific Peptide. The Journal of Immunology. 169(6). 3053–3060. 17 indexed citations
19.
Lévy, Frédéric, Lena Burri, Sandra Morel, et al.. (2002). The Final N-Terminal Trimming of a Subaminoterminal Proline-Containing HLA Class I-Restricted Antigenic Peptide in the Cytosol Is Mediated by Two Peptidases. The Journal of Immunology. 169(8). 4161–4171. 67 indexed citations
20.
Brasseur, Francis, et al.. (2000). Cytolytic T Lymphocytes Raised Against a Human Bladder Carcinoma Recognize an Antigen Encoded by Gene MAGE-A12. The Journal of Immunology. 164(11). 6041–6045. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent Stroobant Breakdown of academic impact, for papers by Peggy Scherle Breakdown of academic impact, for papers by Didier Colau Breakdown of academic impact, for papers by James B. DuHadaway Breakdown of academic impact, for papers by Zhihai Qin Breakdown of academic impact, for papers by Leonard Liebes Breakdown of academic impact, for papers by Donald G. Payan Breakdown of academic impact, for papers by Silvia Deaglio Breakdown of academic impact, for papers by Fabio Malavasi Breakdown of academic impact, for papers by Kjetil Taskén
Rankless by CCL
2026